Targa is a clinically focused biotechnology company possessing key pharmacological assets that increase the manufacturing quality and therapeutic impact of cell therapy /regenerative medicine and opportunities for organ transplantation. Targa's drug discovery and development platform has advanced small molecules optimizing cell manufacturing processes by increasing viable cellular yields during production, post-production and clinical transfer steps, as well as ex vivo enabling to optimize and rescue marginal quality organs for transplantation.
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
